MarketPulse

misleading information

4 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Disc Medicine Stock Plunges 22% After FDA Rejects Bitopertin Drug Application

FDA rejects Disc Medicine's bitopertin drug, triggering 22% stock decline and securities investigation into potential investor losses.
IRONsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··The Rosen Law Firm

Nidec Plunges 22.7% on Accounting Scandal; Class Action Probe Launched

Nidec Corporation ($NJDCY) shares crashed 22.7% after announcing accounting irregularities in its China unit. The Rosen Law Firm is investigating potential securities claims on behalf of affected shareholders.
NJDCYsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··The Rosen Law Firm

Rosen Law Firm Launches Securities Investigation Into Phoenix Education Partners

Rosen Law Firm investigates Phoenix Education Partners for allegedly failing to disclose a major data breach affecting 3.5 million individuals to investors timely.
PXEDsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··The Rosen Law Firm

Law Firm Launches Securities Investigation Into Phoenix Education Partners Following Data Breach

Rosen Law Firm investigates Phoenix Education Partners for allegedly misleading investors about a data breach affecting 3.5 million people. Shareholders encouraged to seek legal counsel.
SMRPXEDPFSIinvestor lossessecurities class action